Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1991-4-10
|
pubmed:abstractText |
A total of 176 patients with gastrointestinal lymphomas were reviewed. According to a modified staging classification, 51 of them had stage I/II disease and the remaining 125 had stage III/IV disease. In most cases (68%), the histology was intermediate-grade according to the NIH working formulation, and the B-cell immunophenotype was involved in 89% of the 45 cases with a known immunophenotype. The primary site was the stomach in 56% of cases and the bowel in 44%. A significantly higher proportion (P = 0.001) of those with bowel lymphomas had stage III/IV disease (88% vs 57%). The primary gastrointestinal lesion was resected in 122 patients, including all 51 cases of stage I/II disease. In all, 8 stage I/II patients were given radiotherapy alone following surgery and the other 43 underwent chemotherapy; of the latter, 19 received additional radiotherapy following chemotherapy. Chemotherapy was also given to 112 stage III/IV patients, 42 of whom underwent additional radiotherapy. Factors associated with a poorer prognosis included advanced disease, bowel lymphoma and advanced age. Although the complete response (CR) rate according to disease stage was similar, stage I/II patients receiving chemotherapy showed a significantly lower relapse rate, better disease-free survival following CR and improved survival as compared with those receiving radiotherapy alone. However, additional radiotherapy following chemotherapy did not further improve the clinical outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1998998-Adolescent,
pubmed-meshheading:1998998-Adult,
pubmed-meshheading:1998998-Aged,
pubmed-meshheading:1998998-Aged, 80 and over,
pubmed-meshheading:1998998-Combined Modality Therapy,
pubmed-meshheading:1998998-Female,
pubmed-meshheading:1998998-Gastrointestinal Neoplasms,
pubmed-meshheading:1998998-Humans,
pubmed-meshheading:1998998-Lymphoma,
pubmed-meshheading:1998998-Male,
pubmed-meshheading:1998998-Middle Aged,
pubmed-meshheading:1998998-Neoplasm Staging,
pubmed-meshheading:1998998-Prognosis,
pubmed-meshheading:1998998-Retrospective Studies,
pubmed-meshheading:1998998-Survival Rate
|
pubmed:year |
1991
|
pubmed:articleTitle |
Chemotherapy for early-stage gastrointestinal lymphoma.
|
pubmed:affiliation |
University Department of Medicine, Queen Mary Hospital, Hong Kong.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|